GMED Globus Medical

  • Official Name: GLOBUS MEDICAL, INC.
  • Headquarters: 2560 General Armistead Ave, AUDUBON, PA, 19403 US
  • CEO: Daniel Scavilla
  • Website: globusmedical.com

Match Results

Date League Week Opponent Result Score
2025-07-15 1R Lost by 3.126 (2.471) - 0.655
2025-07-17 1 Won by 2.578 1.415 - (1.163)
2025-07-24 2 Lost by 6.839 (2.567) - 4.272
2025-07-31 3 Lost by 1.789 (1.247) - 0.542
2025-08-07 4 Won by 5.653 2.499 - (3.154)
2025-08-14 5 Lost by 6.474 9.307 - 15.781
2025-08-21 6 Lost by 1.413 0.753 - 2.166
2025-08-28 7 Won by 1.829 1.145 - (0.684)
2025-09-04 8 Won by 3.842 (1.356) - (5.198)
2025-09-11 9 Lost by 4.364 (1.150) - 3.214
2025-09-18 10 Lost by 16.505 (5.656) - 10.849
2025-09-25 11 Lost by 1.844 (2.743) - (0.899)
2025-10-02 12 Won by 3.156 4.523 - 1.367
2025-10-09 13 Won by 6.574 2.453 - (4.121)
2025-10-16 14 Won by 1.522 (1.784) - (3.306)
2025-10-23 15 Won by 5.992 7.122 - 1.130

Latest News

Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup
Yahoo - 2026-09-25

Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup 🔗

VEEV's AI-powered Study Builder Agent automates clinical study setup, cutting manual work while strengthening its connected Clinical Data ecosyst...

RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection
Yahoo - 2026-09-25

RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection 🔗

Revvity launches a CE-IVDR-certified automated T1D screening kit for children, expanding its GSP platform from newborn screening into early childhood.

Q2 Earnings Highs And Lows: Globus Medical (NYSE:GMED) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
Yahoo - 2026-09-24

Q2 Earnings Highs And Lows: Globus Medical (NYSE:GMED) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks 🔗

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industr...

Can This Number Push ISRG Stock Higher?
Yahoo - 2026-09-24

Can This Number Push ISRG Stock Higher? 🔗

Intuitive Surgical (ISRG) shares fell 10.4% in the past year, while the S&P 500 returned 16.5%. Much of the market has focused on moderating U.S. ...

Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now
Yahoo - 2026-09-24

Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now 🔗

QGEN's test menu expansion and strategic partnerships support growth, but cautious spending and competition may weigh on near-term gains.

Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now
Yahoo - 2026-09-24

Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now 🔗

Glaukos' iDose and Epioxa are driving growth, while recurring treatments, high margins and a broad pipeline support its long-term prospects.

Illumina Stock Surges 94.9% YTD: What's Behind the Rally?
Yahoo - 2026-09-24

Illumina Stock Surges 94.9% YTD: What's Behind the Rally? 🔗

ILMN's 94.9% YTD rally reflects strong sequencing growth, clinical adoption and a raised 2026 outlook despite China headwinds.

Here's Why You Should Retain Baxter Stock in Your Portfolio for Now
Yahoo - 2026-09-24

Here's Why You Should Retain Baxter Stock in Your Portfolio for Now 🔗

BAX's portfolio reset and growth in connected care and advanced surgery support prospects, but margins, Novum IQ and China pricing remain risks.

COO Unveils New Innovation Hub & Lens Launch Plans to Aid CooperVision
Yahoo - 2026-09-24

COO Unveils New Innovation Hub & Lens Launch Plans to Aid CooperVision 🔗

The Cooper Companies opens a global innovation hub in England and unveils six contact lens programs to support sustainable long-term growth.

Veeva Unveils Falcon Router to Streamline Biopharma Case Routing
Yahoo - 2026-09-23

Veeva Unveils Falcon Router to Streamline Biopharma Case Routing 🔗

VEEV launches Falcon Router to automate biopharma case routing, deepening AI integration across regulated life sciences workflows.

Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now
Yahoo - 2026-09-23

Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now 🔗

BIO's Clinical Diagnostics strength and international reach support growth, while China weakness, geopolitics and FX remain key risks.

Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Yahoo - 2026-09-23

Here's Why You Should Hold Stryker Stock in Your Portfolio for Now 🔗

SYK's resilient demand, Mako robotics growth and margin gains support its outlook despite cyber and supply disruptions.

Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx
Yahoo - 2026-09-23

Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx 🔗

NTRA wins Japan PMDA approval for Signatera in muscle-invasive bladder cancer, supporting treatment decisions and a planned 2027 commercial launch.

Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Yahoo - 2026-09-23

Here's Why You Should Retain INSP Stock in Your Portfolio for Now 🔗

Inspire Medical is navigating a major product transition as clinical evidence, patient access efforts and reimbursement progress support growth prospe...

Show more